MAPT and Cognitive impairment: This impact of insulin on tau could explain, at least in part, co-morbidity between DM and AD since tau hyperphosphorylation has been shown to induce tau pathology17, which correlates with the degree of cognitive impairment in Alzheimer’s disease18, 19, 20, 21.